| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Okt―10 |
Association between positive preadmission screening and COVID-19 community transmission: A retrospective observational study during an emergent novel infectious disease pandemic |
Shingo Mitsushima, Yasushi Ohkusa, Kiyosu Taniguchi, Yasuharu Tokuda, Kenji Shibuya |
| 2 |
[GO] |
2025―Sep―10 |
Emergence of the SARS-CoV-2 variant P.1 (Gamma) in Ecuador: A retrospective report of the first confirmed case |
Katty Ojeda-Gutiérrez, Fernando Serrano, David Zúñiga, Sully Márquez, Belén Prado-Vivar, Mónica Becerra Ing, et al. (+5) Juan José Guadalupe, Patricio Rojas-Silva, Verónica Barragán, Paúl Cárdenas, Paola Dalgo Aguilar |
| 3 |
[GO] |
2025―Sep―02 |
Enhanced immunogenicity of COVID-19 RBD fused to mutant scorpion's phospholipase D for vaccine development |
Mohammad-Reza Zareinejad, Mahdi Behdani, Mohammad Taghi Goodarzi, Akbar Oghalaie, Mohammad Hosseininejad-Chafi, Kamran Pooshang-Bagheri, Delavar Shahbazzadeh |
| 4 |
[GO] |
2025―Aug―21 |
COVID-19 in immunocompromised patients: proposed definition of a new entity with prolonged infection |
Ivan Gentile, Nicola Schiano Moriello, Alberto Enrico Maraolo, Rino Rappuoli |
| 5 |
[GO] |
2025―Aug―08 |
An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity |
Isabel H. Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A. Reyes Curcio, Andres E. Franceschi, Chloe Lahoud, et al. (+15) Dimitrios G. Moshovitis, Katherine Beluch, Manu Balusu, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan, Qianwen Wang, Jennifer H. Han, Ahmed Nader, Alicia Aylott, Wei Wang, Brian T. Chan, Sarah P. Hammond, Jennifer Manne-Goehler, Sophia Koo |
| 6 |
[GO] |
2025―Aug―05 |
Nimble Nimbus and emerging SARS-CoV-2 variants - implications for COVID vaccines |
Jaffar A. Al-Tawfiq, Mazin Barry, Hakan Erdem |
| 7 |
[GO] |
2025―Jun―23 |
HKU5-CoV lineage 2 (HKU5-CoV-2): A novel bat-infecting coronavirus with likely ‘spillover’ risk |
Hassan Karami |
| 8 |
[GO] |
2025―Jun―13 |
Strengthening global health Equity: The imperative of the WHO pandemic agreement |
Esam Ibraheem Azhar, Sherif A. El-Kafrawy, Ziad A. Memish |
| 9 |
[GO] |
2025―Mai―20 |
Web-based real-time risk assessment of coronavirus disease 2019 infection in schools and social dining settings |
Yuta Okada, Minami Ueda, Hiroshi Nishiura |
| 10 |
[GO] |
2025―Mai―17 |
Cardiorespiratory Impact of COVID-19 in Young Adults: A Propensity Score-Weighted Cohort Study |
Thibault Lovey, Nejla Gültekin, Zeno Stanga, Andreas Stettbacher, Jeremy Werner Deuel, Patricia Schlagenhauf |
| 11 |
[GO] |
2025―Jan―10 |
Hantavirus Pulmonary Syndrome in a COVID-19 Patient, Bolivia, 2022 |
Wilmer E. Villamil-Gomez, Rosmery Gross, Cristian D. Pacheco-Jiménez, Mariana Aza-Rivera, Alfonso J. Rodriguez-Morales. |
| 12 |
[GO] |
2024―Dez―13 |
Climate change impacts and pandemics |
Shriyansh Srivastava, Rachana Mehta, Aroop Mohanty, Prakasini Satapathy, Ranjit Sah, Vasso Apostoloopoulos |
| 13 |
[GO] |
2024―Dez―07 |
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: a systematic review |
Michelle Bachmann, Nejla Gültekin, Zeno Stanga, Jan S. Fehr, Ismail I. Ülgür, Patricia Schlagenhauf |
| 14 |
[GO] |
2024―Nov―02 |
CONVALESCENT PLASMA THERAPY FOR COVID-19 - DONOR SELECTION STRATEGIES AND ESTABLISHMENT OF A PLASMA BANK |
Mikael Kajova, Tamim Khawaja, Iris Levonen, Jukka-Pekka Pietilä, Jenni Virtanen, Sari H. Pakkanen, et al. (+8) Hanna Välimaa, Arttu Nousiainen, Jussi Hepojoki, Tarja Sironen, Antti Vierikko, Jarkko Ihalainen, Olli Vapalahti, Anu Kantele |
| 15 |
[GO] |
2024―Okt―30 |
Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series |
Shuichi Abe, Dhammika Leshan Wannigama, Yu Suzuki, Daisuke Akaneya, Junko Igarashi, Mayu Suto, et al. (+9) Kazunori Moriya, Daisuke Ishizawa, Yoshikazu Okuma, Parichart Hongsing, Cameron Hurst, Thammakorn Saethang, Paul G. Higgins, Stephen M. Stick, Anthony Kicic |
| 16 |
[GO] |
2024―Okt―30 |
Genetic variability of the recombinant SARS-CoV-2 XEC: is it a new evolutionary dead-end lineage? |
Francesco Branda, Massimo Ciccozzi, Fabio Scarpa |
| 17 |
[GO] |
2024―Okt―24 |
A new and more contagious XEC subvariant of SARS-CoV-2 may lead to massive increase in COVID-19 cases |
Aminath Waafira, Kannan Subbaram, Razana Faiz, Zeba Un Naher, Punya Laxmi Manandhar, Sheeza Ali |
| 18 |
[GO] |
2024―Okt―19 |
Pakistan's first MERS-CoV case: A wake up call for global health authorities |
Keita Wagatsuma |
| 19 |
[GO] |
2024―Aug―31 |
First Human Fatality from H5N2 Virus: Have We Learnt Lessons in Pandemic Preparedness? |
Faithful Miebaka Daniel, Victoria Ezinne Emeruwa, Lydia Daopuye |
| 20 |
[GO] |
2024―Aug―25 |
SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern |
Olajumoke Olufunmilayo Joseph, Samuel Olatunde Dahunsi, Anthony Okoh |
| 21 |
[GO] |
2024―Aug―23 |
Co-infections of SARS-CoV-2 with respiratory syncytial virus and human influenza A in patients with symptoms of COVID-19 in Ghana: A retrospective study |
Kwabena Obeng Duedu, Jones Gyamfi, Reuben Ayivor-Djanie, Godknows Afenya, Isaac Buertey Agbuglah, Hubert Kwame Agbogli, et al. (+3) Priscilla Essandoh, Seraphine Kugbemanya, Theophilus Koku Adiku |
| 22 |
[GO] |
2024―Aug―18 |
Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in adults with Chronic Kidney Disease G4/5. |
Anja Rosdahl, Fredrika Hellgren, Torbjörn Norén, Jessica Smolander, Ursula Wopenka, Karin Loré, Helena Hervius Askling |
| 23 |
[GO] |
2024―Aug―15 |
Automated quantification of SARS-CoV-2 pneumonia with large vision model knowledge adaptation |
Zhaohui Liang, Zhiyun Xue, Sivaramakrishnan Rajaraman, Sameer Antani |
| 24 |
[GO] |
2024―Jun―20 |
Evaluation of MMV Pandemic Response Box compounds to identify potent compounds against clinically relevant bacterial and fungal clinical isolates in vitro |
Seshan Sivasankar, Appalaraju Boppe, Martin Peter Grobusch, Sankarganesh Jeyaraj |
| 25 |
[GO] |
2024―Jun―12 |
Evidence for transmission of SARS-CoV-2 at religious mass gatherings: A systematic review |
Ndiaw Goumballa, Van Thuan Hoang, Jaffar A. Al-Tawfiq, Cheikh Sokhna, Philippe Gautret |
| 26 |
[GO] |
2024―Mai―26 |
An unusual infection of Trichosporon asahii in a COVID-19 patient with diabetes: A rare case report unveiling novel insights highlighting diagnostic challenges and clinical implications |
Zahra Jahani, Zohre Baseri, Amin Dehghan |
| 27 |
[GO] |
2024―Mai―15 |
Investigating the Effects of the Omicron Variant of COVID-19 on Sperm Parameters and Serum Levels of Male Sexual Hormones: prospective observational study. |
Yaser Mohammadi, Javad Ranjbaran, Morteza Mamashli, Hadi Zare Marzuni, Ali Dashtgard, Seyed Mostafa Mohsenizadeh |
| 28 |
[GO] |
2024―Apr―22 |
Feathered Fears: Could Avian H5N1 Influenza Be the Next Pandemic Threat of Disease X? |
Jaffar A. Al-Tawfiq, Raghavendra Tirupathi, Mohamad-Hani Temsah |
| 29 |
[GO] |
2024―Apr―10 |
Transcontinental Insights: Measles Vaccination Strategies in the COVID-19 Era |
Yudai Kaneda |
| 30 |
[GO] |
2024―Mrz―22 |
Expression of Concern: ‘Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients’ |
|
| 31 |
[GO] |
2024―Feb―18 |
Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: A systematic review |
Shiny Talukder, Paroma Deb, Monira Parveen, Kaniz E Zannat, Amirul Huda Bhuiyan, Mahmuda Yeasmin, et al. (+2) Md Maruf Ahmed Molla, KM Saif-Ur-Rahman |
| 32 |
[GO] |
2024―Feb―15 |
Prevalence of Blastocystis sp. and other gastrointestinal pathogens among diarrheic COVID-19 patients in Italy |
Marianna Marangi, Sonia Boughattas, Felice Valzano, Gianfranco La Bella, Rosella De Nittis, Maurizio Margaglione, Fabio Arena |
| 33 |
[GO] |
2024―Feb―05 |
Global spread of COVID-19's JN.1 variant: Implications and public health responses |
Prakasini Satapathy, Pawan Kumar, Vini Mehta, Vinay Suresh, Abhinav Khare, Sarvesh Rustagi, et al. (+4) Mohammad Naeem Dawlati, Mehrab Neyazi, Elyas Najafi, Ahmad Neyazi |
| 34 |
[GO] |
2023―Dez―07 |
Long COVID-associated symptoms prevalent in both SARS-CoV-2 positive and negative individuals: A prospective follow-up study |
Anu Kantele, Juuso Paajanen, Jukka-Pekka Pietilä, Olli Vapalahti, Sari H. Pakkanen, Tinja Lääveri |
| 35 |
[GO] |
2023―Nov―30 |
Trends in SARS-CoV-2 seroprevalence in Albania during the 2021-2022 pandemic year |
Genc Sulcebe, Alban Ylli, Fabian Cenko, Margarita Kurti-Prifti, Erkena Shyti, Jonida Dashi-Pasholli, et al. (+3) Erina Lazri, Irena Seferi-Qendro, Melissa J. Perry |
| 36 |
[GO] |
2023―Nov―16 |
A case of probable COVID-19 and mononucleosis reactivation complicating the presentation of travel-acquired measles |
Sheliza Halani, Gregory Hawley, Andrea K. Boggild |
| 37 |
[GO] |
2023―Nov―07 |
Screening of MMV pandemic response and pathogen box compounds against pan-drug-resistant Klebsiella pneumoniae to identify potent inhibitory compounds |
Seshan Sivasankar, Mari Abinaya Premnath, Appalaraju Boppe, Martin Peter Grobusch, Sankarganesh Jeyaraj |
| 38 |
[GO] |
2023―Okt―30 |
Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients |
Philippe Brouqui, Matthieu Million, Philippe Parola, Peter A. Mccullough, Didier Raoult |
| 39 |
[GO] |
2023―Sep―30 |
Efficacy and safety of in-hospital treatment of Covid-19 infection with low-dose hydroxychloroquine and azithromycin in hospitalized patients: A retrospective controlled cohort study |
Gert Meeus, Frauke Van Coile, Hans Pottel, Ann-Sophie Michel, Ortwin Vergauwen, Katy Verhelle, et al. (+4) Stoffel Lamote, Mathias Leys, Michaël Boudewijns, Pieter Samaey |
| 40 |
[GO] |
2023―Sep―15 |
Association with the actual blood group is the ONLY culprit in ABO and COVID-19 disease severity |
Ali H. Hajeer, Hana M.A. Fakhoury, Tariq Z. Memish, Rana F. Kattan, Ziad A. Memish |
| 41 |
[GO] |
2023―Sep―09 |
Beyond coronavirus: Addressing the escalation of sexually transmitted infections in Japan |
Yudai Kaneda |
| 42 |
[GO] |
2023―Jun―08 |
High prevalence of coronavirus NL63 in SARS-CoV-2 negative COVID-19 suspected patients |
Roya Sadidi, Amir Azimian |
| 43 |
[GO] |
2023―Mai―24 |
COVID-19 and coronary artery disease; A systematic review and meta-analysis |
Bahareh Hajikhani, Mahshid Safavi, Nazila Bostanshirin, Fatemeh Sameni, Mona Ghazi, Shahrooz Yazdani, et al. (+5) Mohammad Javad Nasiri, Nafiseh Khosravi-Dehaghi, Negin Nourisepehr, Saba Sayyari, Masoud Dadashi |
| 44 |
[GO] |
2023―Mai―10 |
2023 Indian Premier League: Potential threat and possible global spread of new SARS-CoV-2 Omicron subvariants including XBB.1.16 - Suggesting strict implementation of traveller guidelines |
Ranjan K. Mohapatra, Snehasish Mishra, Kuldeep Dhama, Lawrence Sena Tuglo, Ranjit Sah |
| 45 |
[GO] |
2023―Apr―27 |
Maternal COVID-19 infection and the fetus: Immunological and neurological perspectives |
Shahab Falahi, Amir Abdoli, Azra Kenarkoohi |
| 46 |
[GO] |
2023―Apr―11 |
COVID-19 vaccine side effects on menstrual disturbances among Iranian women |
Tayebeh Rastegar, Lila Feryduni, Maryam Fakhraei |
| 47 |
[GO] |
2023―Mrz―29 |
Are the issues pointed out by ChatGPT can be applied to Japan? - Examining the reasons behind high COVID-19 excess deaths in Japan |
Yudai Kaneda, Masaharu Tsubokura, Akihiko Ozaki, Hiroaki Saito, Tetsuya Tanimoto |
| 48 |
[GO] |
2023―Mrz―27 |
Contribution of point-of-care laboratories in the molecular diagnosis and monitoring of COVID-19 in Niakhar, Dielmo and Ndiop rural areas in Senegal |
Hubert Bassene, Masse Sambou, Marielle Bedetto, Philippe Colson, Oleg Mediannikov, Ndiaw Goumballa, et al. (+4) Georges Diatta, Philippe Gautret, Florence Fenollar, Cheikh Sokhna |
| 49 |
[GO] |
2023―Mrz―10 |
The next pandemic catastrophe: can we avert the inevitable? |
Maryam Shafaati, Hitesh Chopra, Rekha Khandia, Om Prakash Choudhary, Alfonso J. Rodriguez-Morales |
| 50 |
[GO] |
2023―Feb―23 |
Bibliometric analysis reveals the Mediterranean diet can benefit against coronavirus disease 2019 |
Chenqinyao Li, Ju Hye Baek, Jiazhang Huang, Baolei Jia |
| 51 |
[GO] |
2023―Feb―18 |
Reflection with ChatGPT about the excess death after the COVID-19 pandemic |
Mohamad-Hani Temsah, Amr Jamal, Jaffar A. Al-Tawfiq |
| 52 |
[GO] |
2023―Feb―15 |
What is the Burden of Asymptomatic Coronavirus Infections? |
Jaffar A. Al-Tawfiq, Ziad A. Memish, Kauthar J. Altawfiq, Qiuwei Pan, Patricia Schlagenhauf |
| 53 |
[GO] |
2023―Feb―11 |
The most influential COVID-19 articles: A systematic review |
Suhaib JS. Ahmad, Konstantinos Degiannis, Joseph Borucki, Sjaak Pouwels, David Laith Rawaf, Marion Head, et al. (+8) Chun Hei Li, Rami Archid, Ahmed R. Ahmed, Anil Lala, Wasif Raza, Katie Mellor, Doerte Wichmann, Aristomenis Exadaktylos |
| 54 |
[GO] |
2023―Feb―03 |
SARS-COV-2 IgG specific antibodies persistence in recovered COVID-19 individuals and its association with severity and time of illness |
Abdol Sattar Pagheh, Arash Ziaee, Khadijeh Abrari Romenjan, Fatemeh Rezaea, Babak Bahman, Effat Alamzadeh, et al. (+2) Samira Elhamirad, Masood Ziaee |
| 55 |
[GO] |
2023―Jan―05 |
The global case fatality rate due to COVID-19 in hospitalized elderly patients by sex, year, gross domestic product, and continent: A systematic review, meta-analysis, and meta-regression |
Elham Davtalab Esmaeili, Hosein Azizi, Ehsan Sarbazi, Farzad Khodamoradi |
| 56 |
[GO] |
2022―Dez―27 |
The impact of COVID-19 followed by extreme flooding on vector borne diseases in Pakistan: A mini narrative review |
Zainab Syyeda Rahmat, Mahnoor Sadiq, Laiba Imran Vohra, Hamid Ullah, Mohammad Yasir Essar |
| 57 |
[GO] |
2022―Dez―23 |
Scabicide sales before and during the COVID-19 epidemic in Israel |
Kosta Y. Mumcuoglu, Tomer Hoffman, Eli Schwartz |
| 58 |
[GO] |
2022―Dez―12 |
The efficacy of mouthwashes in reducing SARS-CoV-2 viral loads in human saliva: A systematic review |
Pardis Ziaeefar, Narjes Bostanghadiri, Parsa Yousefzadeh, Julian Gabbay, Amir Hashem Shahidi Bonjar, Mitra Ghazizadeh Ahsaie, et al. (+5) Rosella Centis, Mohammad Sabeti, Giovanni Sotgiu, Giovanni Battista Migliori, Mohammad Javad Nasiri |
| 59 |
[GO] |
2022―Dez―09 |
Frequency, subtypes distribution, and risk factors of Blastocystis sp. in COVID-19 patients in Tehran, capital of Iran: A case-control study |
Ali Taghipour, Majid Pirestani, Ramin Hamidi Farahani, Mohammad Barati, Esfandiar Asadipoor |
| 60 |
[GO] |
2022―Nov―25 |
International air travel-related control measures to contain the Covid-19 pandemic: A companion review to a Cochrane rapid review |
Ameer S-J Hohlfeld, Leila Abdullahi, Ahmed M. Abou-Setta, Mark E. Engel |
| 61 |
[GO] |
2022―Nov―25 |
Clinical characteristics and short-term mortality of 102 hospitalized hemodialysis patients infected with SARS-CoV-2 omicron BA.2.2.1 variant in Shanghai, China |
Wen Jing Bao, Shun Kun Fu, Hua Zhang, Jun Li Zhao, Hui Min Jin, Xiu Hong Yang |
| 62 |
[GO] |
2022―Nov―21 |
Significant impact of vaccination on length of hospital stay and survival in hospitalized patients with COVID-19 |
D.G. Leuning, G.H. Groeneveld, B. Appelman, W.J. Wiersinga, M.G.J. de Boer |
| 63 |
[GO] |
2022―Nov―17 |
Genome Sequence of SARS-CoV-2 Sublineage BA.2.12.1 Strain from Bangladesh |
Arifa Akram, Syed Muktadir Al Sium, Toufiqul Islam, Md. Ashiqur Rahman, MD. Mahbub Ali, Md. Raihanul Islam, et al. (+2) Uttom Kumar Bhowmik, Md Alimur Reza |
| 64 |
[GO] |
2022―Nov―06 |
Social distancing and physical isolation associated -malnutrition and COVID-19 |
Dinh-Toi Chu, Thanh-Lam Nguyen, Jaffar A. Al-Tawfiq, Ziad A. Memish |
| 65 |
[GO] |
2022―Okt―28 |
Nairoby fly and COVID-19, a double hit in the Nepal health system |
Abhigan Babu Shrestha, Aashish Pandey, Sajina Shrestha, Junu Rana Magar |
| 66 |
[GO] |
2022―Okt―28 |
COVID-19 and dengue coinfection in Latin America: A systematic review |
Darwin A. León-Figueroa, Sebastian Abanto-Urbano, Mely Olarte-Durand, Janeth N. Nuñez-Lupaca, Joshuan J. Barboza, D. Katterine Bonilla-Aldana, et al. (+2) Robinson A. Yrene-Cubas, Alfonso J. Rodriguez-Morales |
| 67 |
[GO] |
2022―Okt―21 |
Balint Group work in COVID-19 pandemic: Experience of Iranian healthcare workers in Qualitative Study |
Najmeh Shahini, Mansoureh Kiani Dehkordi, Shakiba Gholamzad, Aziz shamsi, Milad Haidarian |
| 68 |
[GO] |
2022―Sep―20 |
Hajj 2022 and the post pandemic mass gathering: epidemiological data and decision making |
Qanta Ahmed, Ziad A. Memish |
| 69 |
[GO] |
2022―Sep―14 |
A potential monkeypox pandemic: are we making the Same mistakes as COVID-19? |
Ranjit Sah, Abdullah Reda, Abdelaziz Abdelaal, Aroop Mohanty, Abdelmonem Siddiq, Najim Z. Alshahrani, et al. (+2) Fatma A. Amer, Alfonso J. Rodriguez-Morales |
| 70 |
[GO] |
2022―Sep―05 |
The Takara SARS-CoV-2 Direct PCR detection kit delivers reliable results with throat wash specimens |
Moritz Nitsch, Tobias Stahlhut, Oliver Schildgen, Verena Schildgen |
| 71 |
[GO] |
2022―Aug―29 |
Is it possible to eradicate the covid-19 or not? |
Rozhan Khezri, Hossein-Ali Nikbakht, Somayeh Aljalili, Mousa Ghelichi-Ghojogh |
| 72 |
[GO] |
2022―Aug―28 |
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review |
Carlos J. Toro-Huamanchumo, Maryori M. Hilario-Gomez, Liseth Pinedo-Castillo, Carlos J. Zumarán-Nuñez, Fiorella Espinoza-Gonzales, José Caballero-Alvarado, et al. (+2) Alfonso J. Rodriguez-Morales, Joshuan J. Barboza |
| 73 |
[GO] |
2022―Aug―18 |
Clinical challenges of managing advanced AIDS in the Tropics: histoplasmosis, COVID-19, and shigellosis coinfections |
Yeimer Ortiz-Martínez, Luis Daniel Cabeza-Ruiz, Andrés F. Henao-Martínez, Alfonso J. Rodriguez-Morales |
| 74 |
[GO] |
2022―Jul―06 |
First case of within-host co-infection of different SARS-CoV-2 variants in Ecuador |
J.C. Fernandez-Cadena, M. Carvajal, E. Muñoz, B. Prado-Vivar, S. Marquez, S. Proaño, et al. (+11) R. Bayas, J.J. Guadalupe, M. Becerra-Wong, B. Gutierrez, G. Morey-Leon, G. Trueba, M. Grunauer, V. Barragán, P. Rojas-Silva, D. Andrade-Molina, P. Cárdenas |
| 75 |
[GO] |
2022―Jul―04 |
Hit hard in golden hours: Thoughts on preventing the next pandemic |
Dr Sunil Kumar Garg |
| 76 |
[GO] |
2022―Jul―02 |
Correspondence on “Paroxysmal Supra-ventricular Ventricular Tachycardia after COVID-19 Vaccine Injection” |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 77 |
[GO] |
2022―Jul―01 |
Corrigendum to "Does ivermectin have a place in the treatment of mild Covid-19?"[ New Microbes New Infect. (2022) Mar; 46C:100985] |
Eli Schwartz |
| 78 |
[GO] |
2022―Jun―01 |
A Phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease |
G.-S. Dow, B.-L. Smith |
| 79 |
[GO] |
2022―Mai―27 |
High incidence and mortality of COVID-19 among patients with haematological malignancies: an observational study in santander, Colombia |
Yeimer Ortiz-Martínez, Javier E. Fajardo-Rivero, Tania Mendoza-Herrera, Claudia Figueroa-Pineda, Carlos Ruiz-González, Zane Saul, Alfonso J. Rodríguez-Morales |
| 80 |
[GO] |
2022―Mai―27 |
Does ivermectin have a place in the treatment of mild Covid-19? |
Eli Schwartz |
| 81 |
[GO] |
2022―Mai―27 |
Does ivermectin have a place in the treatment of mild Covid-19? |
Eli Schwartz |
| 82 |
[GO] |
2022―Mai―27 |
Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster) |
Verena Schildgen, Jessica Lüsebrink, Oliver Schildgen |
| 83 |
[GO] |
2022―Mai―09 |
COVID-19 in africa: what else? |
Cheikh Sokhna, Souleymane Brah, Abdoulaye Djimde, Nadjet Mouffok, Majida Zahraoui, Ali Ould Mohamed Salem Boukhary, et al. (+12) Idir Bitam, Badara Cisse, Mahamadou Ali Thera, Jean-Bernard Lekana-Douki, Eric Adehossi, Moussa Seydi, Jean Akiana, Jaafar Heikel, Jean-Christophe Lagier, Souleymane Mboup, Jean-Jacques Mouyembe-Tamfum, Philippe Parola |
| 84 |
[GO] |
2022―Apr―11 |
Computational repurposing of asthma drugs as potential inhibitors of SARS-cov-2 mpro |
Afzal Hussain, Ashfaq Hussain |
| 85 |
[GO] |
2022―Mrz―15 |
Cardiomegaly found in hospitalized patients with novel coronavirus disease (COVID-19) |
Zeinab Shankayi, Farideh Bahrami, Tahereh Mohammadzadeh, Amineh Ghafari Anvar, Hosein Amini, M. Mehdi Asadi, et al. (+2) M.Hossein Mirasheh, Mojtaba Sharti |
| 86 |
[GO] |
2022―Mrz―10 |
Illness tracking in SARS-CoV-2 tested persons using a smartphone app: a non-interventional, prospective, cohort study |
Thibault Lovey, Michel Bielecki, Nejla Gültekin, Andreas Stettbacher, Franco Muggli, Zeno Stanga, et al. (+3) Andrea Farnham, Jeremy Deuel, Patricia Schlagenhauf |
| 87 |
[GO] |
2022―Feb―04 |
Alterations in Immune-Inflammatory indexes and Hematological parameters in COVID-19 patients: with positive RT-PCR |
Shaghayegh Moghadam, Behnam Azari, Ali Azhang, Sepideh Hasanzadeh |
| 88 |
[GO] |
2022―Feb―04 |
Paroxysmal Supra-ventricular Ventricular Tachycardia after AstraZeneca COVID-19 Vaccine Injection |
Yi-Tung Lin, Pang-Yen Chen, Yu-Jang Su |
| 89 |
[GO] |
2022―Feb―01 |
The emergence, dynamics and significance of SARS-CoV-2 variants |
Philippe COLSON, Philippe PAROLA, Didier RAOULT |
| 90 |
[GO] |
2022―Jan―24 |
A persistent high ambient temperature waned the community spread of Severe Acute Respiratory Syndrome Coronavirus-2 in Pakistan |
Gul Habib, Muhammad Shah Zeb Khan, Haji Gul, Azam Hayat, Mujaddad Ur Rehman |
| 91 |
[GO] |
2022―Jan―18 |
Sequence analysis for SNP detection and phylogenetic reconstruction of SARS-cov-2 isolated from Nigerian COVID-19 cases |
Idowu A. Taiwo, Nike Adeleye, Fatimah O. Anwoju, Adeyemi Adeyinka, Ijeoma C. Uzoma, Taiwo T. Bankole |
| 92 |
[GO] |
2022―Jan―11 |
Genetic variations from successive whole genome sequencing during COVID-19 treatment in five individuals |
Pasin Hemachudha, Sininat Petcharat, Weenassarin Ampoot, Teerada Ponpinit, Leilani Paitoonpong, Thiravat Hemachudha |
| 93 |
[GO] |
2022―Jan―07 |
A systematic review on SARS-CoV-2 remission: an Emerging challenge for its management, treatment, immunization strategies and post-treatment guidelines |
Rupa Joshi, Rubal Singla, Abhishek Mishra, Mukesh Kumar, Rahul Soloman Singh, Ashutosh Singh, et al. (+5) Seema Bansal, Amit Raj Sharma, Phulen Sarma, Ajay Prakash, Bikash Medhi |
| 94 |
[GO] |
2022―Jan―07 |
First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador |
Andrés Carrazco-Montalvo, Isaac Armendáriz-Castillo, Clara Lucía Tello, Diego Morales, Rubén Armas-Gonzalez, David Guizado-Herrera, et al. (+14) Ariana León-Sosa, Daniel Ramos-Sarmiento, Byron Fuertes, Leandro Patino, Paúl Cárdenas, Sully Márquez, Belén Prado-Vivar, Juan José Guadalupe, Bernardo Gutiérrez, Mónica Becerra Wong, Michelle Grunauer, Gabriel Trueba, Patricio Rojas-Silva, Verónica Barragán |
| 95 |
[GO] |
2021―Sep―21 |
NEUTROPHILS and SECONDARY INFECTIONS in COVID-19 INDUCED acute respiratory distress syndrome |
Zachary M. Holliday, Mohammed M. Alnijoumi, Mark A. Reed, Alexander P. Earhart, Adam G. Schrum, Lee-Ann H. Allen, Armin Krvavac |
| 96 |
[GO] |
2021―Sep―04 |
Evaluation of the therapeutic effect of the plasma of recovered Covid-19Patients for treating the patients admitted to the intensive care unit |
Abas Ghaysouri, Hassan Nourmohammadi, Esmaeel Qasemi, Ali Ashraf Mozafari, Hamed Tavan, Sanaz Saghari |
| 97 |
[GO] |
2021―Sep―03 |
Incidence, characteristics, and outcome of COVID-19 in patient on liver transplant program: a retrospective study in north of Iran |
Pirouz Samidoust, Mohammad Sadegh Esmaeili Delshad, Mostafa Navid Talemi, Kourosh Mojtahedi, Aryan Samidoust, Soghra Jahangiri, Mohammad Taghi Ashoobi |
| 98 |
[GO] |
2021―Sep―02 |
The effect of Hemoperfusion on Outcome, Clinical and Laboratory findings of Patients with Severe COVID-19: A Retrospective Study |
Alireza Soleimani, Seyed-Masoud Moeini Taba, Sara Hasibi Taheri, Amir Hossein Loghman, Mohammad Shayestehpour |
| 99 |
[GO] |
2021―Sep―01 |
Association between ABO blood groups and Rhesus antigen and susceptibility to COVID-19 in the Yazd hospital |
Emad Behboudi, Vahideh Hamidi, Fatemeh Gholizadeh, Emilia Maria Grala, Yaser Ghelmani, Mohsen Nakhaie, et al. (+2) Javad Charostad, Akram Astani |
| 100 |
[GO] |
2021―Aug―03 |
Ivermectin: a multifaceted drug of Nobel prize-honored distinction with indicated efficacy against a new global scourge, COVID-19 |
Alessandro D. Santin, David E. Scheim, Peter A. McCullough, Morimasa Yagisawa, Thomas J. Borody |
| 101 |
[GO] |
2021―Aug―02 |
SARS-CoV-2 Reinfection in Patients Negative for Immunoglobulin G Following Recovery from COVID-19 |
Ayad M. Ali, Kameran Mohammed Ali, Mohammed Hassan Fatah, Hassan Mohammad Tawfeeq, Hassan Muhammad Rostam |
| 102 |
[GO] |
2021―Jul―24 |
Genetic emergence of B.1.617.2 in COVID-19 |
Laxmi Kirola |
| 103 |
[GO] |
2021―Jul―24 |
The forgotten oral microbial transplantation for improving the outcomes of COVID-19 |
Antoine AbdelMassih, Mahenar Gadalla, Engy Hussein, Maryam Elahmady, Nihal Zahra, Maryam A. Eid, et al. (+17) Mahinour Hussein, Alaa A. Hassan, Aya S. Abou-Zeid, Aya Hassan, Nadine El Nahhas, Nadine Emad, Nour Aboushadi, Nourhan Ibrahim, Sherouk Mokhtar, Nadine El-Husseiny, Aya Kamel, Rafeef Hozaien, Esraa Menshawey, Habiba-Allah Ismail, Mokhtar Mokhles, Rahma Menshawey, Raghda Fouda |
| 104 |
[GO] |
2021―Jul―24 |
Evaluation of serum procalcitonin level as a biomarker for disease severity in Covid-19 patients |
Abdul Waris, Misbahud Din, Nouman Iqbal, Lubna Yar, Atiqa Khalid, Mehboob Nawaz, et al. (+2) Abdul Baset, Muhammad Ali |
| 105 |
[GO] |
2021―Jul―24 |
Ozone eliminates Novel Coronavirus Sars-CoV-2 in mucosal samples |
Fabio Sallustio, Gaetano Cardinale, Serena Voccola, Angela Picerno, Piercarmine Porcaro, Loreto Gesualdo |
| 106 |
[GO] |
2021―Jul―17 |
Quantitative analysis of taste disorder in COVID-19 patients, the hypersensitivity to salty quality |
M. Mahdi Asadi, Zeinab Shankayi, Farideh Bahrami, Tahereh Mohammadzadeh, Hossein Amini, Maryam Naderi |
| 107 |
[GO] |
2021―Jul―16 |
Unraveling the origin of SARS-CoV-2: is the model good? |
Roger Frutos, Laurent Gavotte, Christian A. Devaux |
| 108 |
[GO] |
2021―Jul―13 |
Evaluation of the Covid-19 pandemic effect on the development of somatic symptoms in patients with mood disorders: A Case-Control study |
Najmeh Shahini, Zanireh Salimi, Mehman Javan, Mohammadzaman Kamkar |
| 109 |
[GO] |
2021―Jul―13 |
Low sensitivity of SARS-CoV-2 Rapid antigen self-tests under laboratory conditions |
Sabrina Demuth, Sarah Damaschek, Oliver Schildgen, Verena Schildgen |
| 110 |
[GO] |
2021―Jul―07 |
Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Significantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients |
Flavio A. Cadegiani, Andy Goren, Carlos G. Wambier, John McCoy |
| 111 |
[GO] |
2021―Jul―04 |
Knowledge, Attitude and Associated Factors toward COVID-19 among Nurses Who Work in South Gondar Zone, Hospitals, Northwest Ethiopia 2020. A multi central Institutional based cross sectional study |
Dejen Getaneh Feleke, Ermiase Sisay Chanie, Birara Ayichew Tilaye, Demeke Mesfin, Biniam Munye Bayih, Wubet Alebachew Bayih, et al. (+6) Sheganew Fetene Tassew, Sentayehu Asnakew, Tekalign Amera Berlie, Tadela Dires, Enyew Dagnaw, Tesfaye Yimer Tadesse |
| 112 |
[GO] |
2021―Jul―01 |
Bacterial Co-infection among COVID-19 patient groups: an update Systematic review and Meta-analysis |
Saber Soltani, Samireh Faramarzi, Milad Zandi, Ramin Shahbahrami, Ali Jafarpour, Sara Akhavan Rezayat, et al. (+4) Iraj Pakzad, Fatemeh Abdi, Pooneh Malekifar, Reza Pakzad |
| 113 |
[GO] |
2021―Mai―20 |
Gender based differences in COVID-19 |
Yu-Jang Su, Kuan-Chih Kuo, Ta-Wei Wang, Chen-Wang Chang |
| 114 |
[GO] |
2021―Mai―19 |
AIDS & COVID-19 infections: Impact on vulnerable Indian Population |
Saurabh Kumar |
| 115 |
[GO] |
2021―Mai―18 |
Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study |
Masoud Keikha, Mohsen Karbalaei |
| 116 |
[GO] |
2021―Mai―17 |
Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with Covid-19 |
Behrouz Karkhanei, Elaheh Talebi Ghane, Fereshteh Mehri |
| 117 |
[GO] |
2021―Mai―14 |
The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
Giorgia Caruana, Laure-Line Lebrun, Oriane Aebischer, Onya Opota, Luis Urbano, Mikael de Rham, et al. (+2) Oscar Marchetti, Gilbert Greub |
| 118 |
[GO] |
2021―Mai―08 |
Re-infection or Relapse of COVID-19 in Health Care workers; case series of 2 Patients from Pakistan |
Abeera Ahmed, Fatima Sana, Aamer Ikram, Shagufta Yousaf, Aysha Khan |
| 119 |
[GO] |
2021―Mai―07 |
A mini-review on Sofosbuvir and Daclatasvir treatment in COVID-19 |
Mehdi Shabani, Bahar Sadegh Ehdaei, Farshid Fathi, Razieh Dowran |
| 120 |
[GO] |
2021―Apr―24 |
Distinguishing COVID-19 from influenza in children remains challenging |
Souheil Zayet, Timothée Klopfenstein, Nicoleta Ursulescu, Nabil Belfeki, Vincent Gendrin, Molka Osman |
| 121 |
[GO] |
2021―Apr―24 |
Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020 |
Sultana Zahura Afrin, Shyamal Kumar Paul, Jahan Ara Begum, Syeda Anjuman Nasreen, Salma Ahmed, Fahim Uddin Ahmad, et al. (+4) Md. Abdul Aziz, Rokshana Parvin, Meiji Soe Aung, Nobumichi Kobayashi |
| 122 |
[GO] |
2021―Apr―23 |
Is the HIT-like syndrome associated with ChAdOx vaccine related to the vaccine itself or an autoimmune reaction to SARS-CoV-2, insights and implications from previous reports in infected cases? |
Antoine AbdelMassih, Rafeef Hozaien, Meryam El Shershaby, Aya Kamel, Habiba-Allah Ismail, Raghda Fouda |
| 123 |
[GO] |
2021―Apr―08 |
First detection of the British variant of SARS-CoV-2 in Senegal |
Abdou Padane, Abdoulie Kanteh, Nafissatou Leye, Aminata Mboup, Jarra Manneh, Moustapha Mbow, et al. (+15) Papa Alassane Diaw, Birahim Pierre Ndiaye, Gora Lo, Cheikh Ibrahima Lo, Ambroise Ahoudi, Astou Gueye-Gaye, Jean Jacques Nsoumou Malomar, Aminata Dia, Yacine Amet Dia, Ndeye Diabou Diagne, Djibril Wade, Abdul Karim Sesay, Ndeye Coumba Toure-Kane, Umberto Dalessandro, Souleymane Mboup |
| 124 |
[GO] |
2021―Mrz―31 |
Computational Insights of phytochemical Driven Disruption of RNA dependent RNA polymerase Mediated replication of Coronavirus: A Strategic Treatment Plan against COVID-19 |
Acharya Balkrishna, Rashmi Mittal, Gunjan Sharma, Vedpriya Arya |
| 125 |
[GO] |
2021―Mrz―31 |
TRIzol-Based RNA extraction for detection protocol for SARS-CoV-2 of the coronavirus Disease 2019 |
Amirouche Adel, Ait-Ali Djida, Nouri Hamid, Boudrahme-Hannou Lila, Tliba Souhil, Ghidouche Abderrezak, Bitam Idir |
| 126 |
[GO] |
2021―Mrz―25 |
Assessment of awareness and hygiene practices regarding COVID-19 among adults in Gaza, Palestine |
A.M. Altaher, A.E.Y. Elottol, M.A. Jebril, S.H. Aliwaini |
| 127 |
[GO] |
2021―Mrz―23 |
A 33-year-old man with COVID-19 presented with subacute thyroiditis: A rare case report |
Lotfollah Davoodi, Ziaeddin Oladi, Hamed Jafarpour, Zakaria Zakariae, Eissa Soleymani, Alireza Razavi |
| 128 |
[GO] |
2021―Mrz―20 |
The second wave of desaturation in COVID-19 |
Mohd Islam Alghizzawi, Fateen Ata, Zohaib Yousaf, Mousa Ahmad Alhiyari, Ammara Bint I Bilal, Abdelhaleem Ahmed Elhiday, Ahmad Salih Abdulhadi |
| 129 |
[GO] |
2021―Mrz―20 |
The frequency of arrhythmias in COVID-19 patients, a study in the Shahid Mostafa Khomeini Hospital of Ilam from March to August 2020 |
Elham Mohammadyari, Iraj Ahmadi, Anis Mohammadyari, Hamed Tavan, Siros Norozi |
| 130 |
[GO] |
2021―Mrz―20 |
The Nipah virus: A potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus-2 pandemic |
Popy Devnath, H. M. Abdullah Al Masud |
| 131 |
[GO] |
2021―Feb―27 |
Changes in respiratory diseases in Chongqing Health Center for Women and Children during COVID-19 |
Xu Xiaoxiao, Xu Mingdeng, Li Xuemei |
| 132 |
[GO] |
2021―Feb―27 |
HIV and COVID-19; impact on vulnerable population and harnessing lessons learnt from HIV programs |
Ahmed Cordie, Mohamed AbdAllah, Alessandra Vergori, Brenda Kharono, Mehdi Karkouri, Gamal Esmat |
| 133 |
[GO] |
2021―Feb―27 |
Severe acute respiratory syndrome coronavirus 2 may exploit human transcription factors involved in retinoic acid and interferon-mediated response: a hypothesis supported by an in-silico analysis |
Ighli di Bari, Rossana Franzin, Angela Picerno, Alessandra Stasi, Maria Teresa Cimmarusti, Mariagiovanna Di Chiano, et al. (+8) Claudia Curci, Paola Pontrelli, Maria Chironna, Giuseppe Castellano, Anna Gallone, Carlo Sabbà, Loreto Gesualdo, Fabio Sallustio |
| 134 |
[GO] |
2021―Feb―24 |
Challenges and potential solutions in the development of COVID-19 pandemic control measures |
Hosein Azizi, Elham Davtalab Esmaeili |
| 135 |
[GO] |
2021―Feb―17 |
Co-epidemics: Have measures against COVID-19 helped to reduce Lassa fever cases in Nigeria? |
Rine Christopher Reuben, Silas Dogara Gyar, Makwin Danladi Makut, Moses P. Adoga |
| 136 |
[GO] |
2021―Feb―15 |
Who is a potential risk groups to coronavirus disease 2019 (COVID-19) A-Review |
Muhammad Naveed, Muhammad Naeem, Mujeeb ur Rahman, Mian Gul Hilal, Mian Adnan Kaka Khel, Gohar Ali, Adil Hassan |
| 137 |
[GO] |
2021―Feb―15 |
COVID-19-associated spontaneous subacute subdural hematoma; report of two cases |
Alireza Tabibkhooei, Jaber Hatam, Mahisa Mokhtari, Meysam Abolmaali |
| 138 |
[GO] |
2021―Feb―15 |
What about rheumatic diseases and Covid-19? |
Hani Amir Aouiss, Imene Belhaouchet |
| 139 |
[GO] |
2021―Jan―24 |
Chloroquine and COVID-19: role as a bitter taste receptor agonist? |
Belaid Bouazza, Idir Ramdani, Rachid Chahed |
| 140 |
[GO] |
2021―Jan―12 |
A multi-centric, cross-sectional study on COVID-19 in Bangladesh: clinical epidemiology and short-term outcomes in recovered individuals |
Adnan Mannan, H.M. Hamidullah Mehedi, Naim Uddin Hasan A Chy, Md. Omar Qayum, Farhana Akter, Abdur Rob, et al. (+3) Prasun Biswas, Sanjida Hossain, Mustak Ibn Ayub |
| 141 |
[GO] |
2021―Jan―10 |
Oral probiotics in COVID-19: connecting the gut-lung axis to viral pathogenesis, inflammation, secondary infection, and clinical trials |
Piyush Baindara, Ranadhir Chakraborty, Zachary M. Holliday, Santi M. Mandal, Adam G. Schrum |
| 142 |
[GO] |
2021―Jan―01 |
ARDS during the COVID-19 pandemic: not only SARS-CoV-2 |
Patrick M. Meyer Sauteur, Gian-Reto Kleger, Werner C. Albrich |
| 143 |
[GO] |
2020―Dez―17 |
A single nucleotide distinguishes SARS-CoV-2 in Wuhan outbreak in December 2019 from that in Beijing-Xinfadi in June 2020, China |
Yuan-Qing Pan, Amina Nawal Bahoussi, Fan Guo, Li Xing |
| 144 |
[GO] |
2020―Dez―10 |
Total containment of the population and number of confirmed cases of covid-19 in England, Belgium, France and Italy |
Giscard Assoumou-Ella |
| 145 |
[GO] |
2020―Dez―06 |
COVID-19 re-infection or persistent infection in patient with Acute Myeloid Leukemia M3; A mini review |
Hamed Azhdari Tehrani, Maryam Darnahal, Seyed Alireza Nadji, Shirin Haghighi |
| 146 |
[GO] |
2020―Nov―24 |
Epidemiology of COVID-19 in Algeria |
M. Lounis |
| 147 |
[GO] |
2020―Nov―21 |
Assessment of schistosomiasis endemicity and preventive treatment on coronavirus disease 2019 outcomes in Africa |
Oyetunde T. Oyeyemi, Oluyemi A. Okunlola, Adebowale D. Adebayo |
| 148 |
[GO] |
2020―Nov―20 |
Universal admission screening strategy for COVID-19 highlighted the clinical importance of reporting SARS-CoV-2 viral loads |
M. Moraz, D. Jacot, M. Papadimitriou-Olivgeris, L. Senn, G. Greub, K. Jaton, O. Opota |
| 149 |
[GO] |
2020―Nov―19 |
SARS-COV2 and P. falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt |
Mohamed AM. Iesa, Makarim EM. Osman, Mohamed A. Hassan, Amina IA. Dirar, Nadir Abuzeid, James J. Mancuso, et al. (+5) Ritu Pandey, Arwa A. Mohammed, Mitesh J. Borad, Hani M. Babiker, Emadeldin HE. Konozy |
| 150 |
[GO] |
2020―Nov―17 |
COVID-19 presenting as acute abdomen and sepsis: a rare case-report |
Abdulrahman Alharthy, Abdullah Balhamar, Fahad Faqihi, Nasir Nasim, AlFateh Noor, Saleh A. Alqahtani, et al. (+2) Ziad A. Memish, Dimitrios Karakitsos |
| 151 |
[GO] |
2020―Nov―17 |
Mass culling of minks to protect the COVID-19 vaccines: is it rational? |
R. Frutos, C.A. Devaux |
| 152 |
[GO] |
2020―Nov―13 |
Use of convalescent plasma therapy in Eight mild COVID-19 patients |
Fang Ji, Wen Liu, Da-ang Hao, Juan Cheng, Xue-cheng Tong, Jun-gui Hao, et al. (+4) Li-ping Wang, Chun-yang Li, Ming-jia Dai, Xue-bing Yan |
| 153 |
[GO] |
2020―Nov―13 |
Natural history of COVID-19: Back to the Basics |
Souheil Zayet, Vincent Gendrin, Timothee Klopfenstein |
| 154 |
[GO] |
2020―Nov―12 |
Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health care workers |
Iana Simova, Toni Vekov, Jordan Krasnaliev, Vladimir Kornovski, Plamen Bozhinov |
| 155 |
[GO] |
2020―Nov―12 |
COVID-19 re-infection: prolonged shedding or true reinfection |
Shahab Falahi, Azra Kenarkoohi |
| 156 |
[GO] |
2020―Nov―12 |
Herd-immunity against COVID-19: Is it enough to stop a second wave? |
Mohamed AbdAllah, Ahmed Cordie |
| 157 |
[GO] |
2020―Nov―07 |
Evaluation of electrolytes status of sodium, potassium, magnesium, and fasting blood sugar at the initial admission of COVID-19 patients without underlying disease in Golestan Hospital, Kermanshah |
Hosna Sarvazad, Shahab Cahngaripour, Narges Eskandari Roozbahani, Babak Izadi |
| 158 |
[GO] |
2020―Okt―31 |
The burden and outcomes of COVID-19 among patients with comorbid disease in Africa: protocol for a systematic review and meta-analysis |
Woldu Aberhe, Teklewoini Mariye, Abrha Hailay, Kidane Zereabruk, Guesh Mebrahtom, Gebreamlak Gebremedhn, et al. (+2) Teklehaimanot Haile, Teklay Guesh |
| 159 |
[GO] |
2020―Okt―28 |
COVID-19: Scientific Overview of the global Pandemic |
Anusree Dey, Rituparna Das, Hari Sharan Misra, Sheetal Uppal |
| 160 |
[GO] |
2020―Okt―19 |
Clinical and epidemiological features of COVID-19 deaths in Nepal |
Bimala Panthee, Saraswati Dhungana, Nirmal Panthee, Saroj Gyawali, Atmika Paudel, Suresh Panthee |
| 161 |
[GO] |
2020―Okt―17 |
Increasing and declining of COVID-19 cases puzzling the health experts in Pakistan |
Pir Tariq Shah, Li Xing |
| 162 |
[GO] |
2020―Okt―17 |
Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran |
Seyedehmozhdeh Mirmohammadi, Anvarsadat Kianmehr, Mohammad Arefi, Abdolkarim Mahrooz |
| 163 |
[GO] |
2020―Okt―15 |
Retrospective overview of the coronavirus disease 2019 (COVID-19) outbreak in Mauritania |
Abdallahi El Vally, Mohamed Abdallahi Bollahi, Mohamed Salem Ould Ahmedou Salem, Jemila Deida, Philippe Parola, Leonardo Basco, et al. (+3) Ahmed El Bara, Mohamed Ouldadallahi, Ali Ould Mohamed Salem Boukhary |
| 164 |
[GO] |
2020―Okt―14 |
Knowledge, attitude, practice and psychological response toward COVID-19 among nurses during the COVID-19 outbreak in Northern Ethiopia, 2020 |
Degena Bahrey Tadesse, Gebremeskel Tukue Gebrewahd, Gebre Teklemariam Gebre |
| 165 |
[GO] |
2020―Okt―14 |
COVID-19 with spontaneous pneumothorax, pneumomediastinum and subcutaneous emphysema |
Souheil Zayet, Timothee Klopfenstein, Chaouki Mezher, Vincent Gendrin, Thierry Conrozier, Yousri Ben Abdallah |
| 166 |
[GO] |
2020―Okt―14 |
Development of a novel platform of virus-like particle (VLP) based vaccine against coronavirus 2019 (SARS-CoV-2) by exposing of epitopes: an immunoinformatics approach |
Abozar Ghorbani, Fatemeh Zare, Sima Sazegari, Alireza Afsharifar, Mohammad Hadi Eskandari, Ali Pormohammad |
| 167 |
[GO] |
2020―Okt―13 |
Report of four pregnant women getting COVID-19 in Ilam, Iran: Case Series |
Ali Gheysarzadeh, Nourkhoda Sadeghifard, Maryam Safari, Tayebeh Rashidian, Elham Mohammadyari, Hamed Tavan |
| 168 |
[GO] |
2020―Okt―10 |
Role of micronutrients in the management of COVID-19 |
Mohamed AbdAllah, Hanan Ez Elarab, Eman Raslan, Lobna Saber, Eitedal Daoud, Maha Saber |
| 169 |
[GO] |
2020―Okt―10 |
Stroke in a young adult with mild COVID-19 suggesting endotheliitis |
Selina Crippa, Georg Kägi, Lukas Graf, Patrick M. Meyer Sauteur, Philipp Kohler |
| 170 |
[GO] |
2020―Okt―08 |
Challenges and accurate estimates of the Mortality and Case Fatality Rates by COVID-19 |
Hosein Azizi, Elham Davtalab Esmaeili, Ali Fakhari |
| 171 |
[GO] |
2020―Okt―06 |
Transmission routes for SARS-COV-2 infection: Review of Evidence |
Shahab Falahi, Azra Kenarkoohi |
| 172 |
[GO] |
2020―Okt―05 |
Demographics, laboratory parameters and outcomes of 1061 patients with COVID-19: A report from Tehran, Iran |
Mihan Pourabdollah Toutkaboni, Elham Askari, Nastaran Khalili, Payam Tabarsi, Hamidreza Jamaati, Ali Akbar Velayati, et al. (+5) Atosa Dorudinia, Mitrasadat Rezaei, Seyed Alireza Nadji, Abdolreza Mohamadnia, Neda Khalili |
| 173 |
[GO] |
2020―Okt―05 |
Hydroxychloroquine is effective, and consistently so used early, for Covid-19: A systematic review |
Chadwick Prodromos, Tobias Rumschlag |
| 174 |
[GO] |
2020―Okt―04 |
Covid-19 Re-Infection: First Report from Turkey |
Resat Ozaras, Ibrahim Ozdogru, Ahmet Atilla Yilmaz |
| 175 |
[GO] |
2020―Sep―30 |
Diagnostic approaches and potential therapeutic options for coronavirus disease (COVID-19) |
Zafran Khan, Dawood Ghafoor, Asaf Khan, Daniya Ualiyeva, Shahzad Akbar Khan, Hazrat Bilal, et al. (+3) Babar Khan, Ayub Khan, Wasim Sajjad |
| 176 |
[GO] |
2020―Sep―29 |
Remdesivir investigational trials in COVID-19: a critical reappraisal. REVISED v2 |
P. Brouqui, A. Giraud-Gatineau, D. Raoult |
| 177 |
[GO] |
2020―Sep―22 |
Individuals with “A” Rh-positive but not Rh-negative blood group are more vulnerable to SARS-COV-2 infection: Demographics and trend study on COVID-19 cases in Sudan |
Safa Abdallah H. Taha, Makarim Elfadil M. Osman, Esameldeen Ahmed A. Abdoelkarim, Mohamed A. Ibrahim Holie, Mohamed M. Elbasheir, Nadir Musa K. Abuzeid, et al. (+3) Saed A. Al-Thobaiti, Sharief B. Fadul, Emadeldin Hassan E. Konozy |
| 178 |
[GO] |
2020―Sep―22 |
What could explain the late emergence of COVID-19 in Africa? |
Rym Lalaoui, Sofiane Bakour, Didier Raoult, Pierre Verger, Cheikh Sokhna, Christian Devaux, et al. (+2) Bruno Pradines, Jean-Marc Rolain |
| 179 |
[GO] |
2020―Sep―16 |
Diagnosis of COVID-19: Facts and challenges |
Haider Hashim Zalzala |
| 180 |
[GO] |
2020―Sep―16 |
Socio-economic inequality in global incidence and mortality rates from coronavirus disease 2019: an ecological study |
F. Shahbazi, S. Khazaei |
| 181 |
[GO] |
2020―Sep―07 |
Preliminary report of In vitro and In vivo Effectiveness of Dornase alfa on SARS-CoV-2 infection |
Hacer Kuzu Okur, Koray Yalcin, Cihan Tastan, Sevda Demir, Bulut Yurtsever, Gozde Sir, et al. (+13) Derya Dilek Kancagi, Selen Abanuz, Utku Seyis, Rehile Zengin, Cansu Hemsinlioglu, Mujdat Kara, Mehmet Erdem Yildiz, Elif Deliceo, Nur Birgen, Nil Banu Pelit, Caglar Cuhadaroglu, Ayse Sesin Kocagoz, Ercument Ovali |
| 182 |
[GO] |
2020―Sep―02 |
Statins-based prophylactic mouthwash and nasal spray may protect against COVID-19 |
Saleem Abdulrab, Baleegh Alkadasi, Sadeq Al-maweri, Esam Halboub, Hatem Alhadainy, Greta Geerts |
| 183 |
[GO] |
2020―Sep―01 |
Clinical and immunological features among COVID-19 affected mother-infant pairs: antibodies to SARS- CoV- 2 detected in breast milk |
Xuan Gao, Shaoshuai Wang, Wanjiang Zeng, Suhua Chen, Jianli Wu, Xingguang Lin, et al. (+3) Yanyan Liu, Ziyong Sun, Ling Feng |
| 184 |
[GO] |
2020―Sep―01 |
Baseline electrolyte abnormalities would be related to poor prognosis in hospitalized COVID-19 patients |
Mehmet Engin Tezcan, Gizem Dogan gokce, Nesrin Sen, Nilufer Zorlutuna kaymak, Rasit Serdar Ozer |
| 185 |
[GO] |
2020―Sep―01 |
Pandemic and social changes, political fate |
Hicham Elbazidi, Othmane Erraih |
| 186 |
[GO] |
2020―Aug―27 |
Are two consecutive negative RT-PCRs enough to rule out COVID-19? |
Rami Waked, Jennifer Makhoul, Gebrael Saliba, Nabil Chehata, Sadek Mortada, Antoine Zoghbi, et al. (+2) Jacques Choucair, Elie Haddad |
| 187 |
[GO] |
2020―Aug―20 |
Re-positive COVID-19 PCR test: could it be a reinfection? |
Ahmed A. Osman, Manal M. Al Daajani, Abdullah J. Alsahafi |
| 188 |
[GO] |
2020―Aug―18 |
The current situation of COVID-19 in Sudan |
Hisham N. Altayb, Nassma Mohy Eldeen Altayeb, Yassir Hamadalnil, Mohieldin Elsayid, Neama Esmat Mahmoud |
| 189 |
[GO] |
2020―Aug―11 |
Fatal case of HIV and COVID-19 |
Muhammed Elhadi, Ahmed Abdulhakim Momen, Osama Mohamed Ali Senussi Abdulhadi, Ahmed Msherghi |
| 190 |
[GO] |
2020―Aug―11 |
Exploring the causes of mild COVID-19 involvement in pediatric patients |
Alvand Naserghandi, Reyhaneh Saffarpour, Seyed Farshad Allameh |
| 191 |
[GO] |
2020―Aug―11 |
Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis |
Fatemeh Pourali, Mahdi Afshari, Reza Alizadeh-Navaei, Javad Javidnia, Mahmood Moosazadeh, Amirhossein Hessami |
| 192 |
[GO] |
2020―Aug―07 |
Challenges in an asthmatic child with COVID-19 |
M. Kamali Aghdam, M. Sadeghzadeh, S. Sadeghzadeh, K. Namakin |
| 193 |
[GO] |
2020―Aug―05 |
COVID-19: Pathophysiology, diagnosis, complications and Investigational therapeutics |
Samy A. Azer |
| 194 |
[GO] |
2020―Aug―05 |
COVID-19: the current situation in Nepal |
Bimala Panthee, Saraswati Dhungana, Nirmal Panthee, Atmika Paudel, Saroj Gyawali, Suresh Panthee |
| 195 |
[GO] |
2020―Jul―31 |
The first two-month epidemiology COVID-19, the social dynamics of the outbreak, related public health preparedness and response to the ongoing epidemic in Pakistan |
Mian Adnan Kakakhel, Fasi Wu, Taj Ali Khan, Huyuan Feng, Zubair Hassan, Zahid Anwar, et al. (+3) Shah Faisal, Ihsan Ali, Wanfu Wang |
| 196 |
[GO] |
2020―Jul―28 |
Diagnostic stumbling blocks in the COVID-19 monitoring of medical staff while putting hygiene requirements into practice |
Verena Schildgen, Jessica Lüsebrink, Panagiotis Thomaidis, Philipp Meibert, Oliver Schildgen |
| 197 |
[GO] |
2020―Jul―23 |
COVID-19 infection recurrence presented with meningoencephalitis |
Seyed Alireza Nadji, Kouros Aghazadeh Sarhangipor, Athena Sharifi-Razavi, Mana Baziborun |
| 198 |
[GO] |
2020―Jul―18 |
Letter to the Editor on "Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences" by Roussel and Raoult (2020) |
Hans-Peter Piepho |
| 199 |
[GO] |
2020―Jun―24 |
Mild SARS-COV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress (ROS) and antioxidant capabilities |
Eyup S. Keles |
| 200 |
[GO] |
2020―Jun―14 |
Serial interval and time-varying reproduction number estimation for COVID-19 in West of Iran |
Farid Najafi, Neda Izadi, Seyed-Saeed Hashemi-Nazari, Fatemeh Khosravi-Shadmani, Roya Nikbakht, Ebrahim Shakiba |
| 201 |
[GO] |
2020―Jun―14 |
Phyloevolutionary analysis of SARS-CoV-2 in Nigeria |
Awoyelu Elukunbi Hilda, Oladipo Elijah Kolawole, Adetuyi Babatunde Olufemi, Tosin Yetunde Senbadejo, Olubukola Monisola Oyawoye, Oloke Julius Kola |
| 202 |
[GO] |
2020―Jun―14 |
Laboratory diagnosis of SARS-CoV-2: available approaches and limitations |
Jameel M. Abduljalil |
| 203 |
[GO] |
2020―Jun―07 |
Remdesivir investigational trials in COVID-19: a critical reappraisal |
P. Brouqui, A. Giraud-Gatineau, D. Raoult |
| 204 |
[GO] |
2020―Jun―06 |
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences |
Yanis Roussel, Didier Raoult |
| 205 |
[GO] |
2020―Jun―06 |
Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world |
Matthieu Million, Philippe Gautret, Philippe Colson, Yanis Roussel, Gregory Dubourg, Eric Chabriere, et al. (+8) Stéphane Honore, Jean-Marc Rolain, Florence Fenollar, Pierre-Edouard Fournier, Jean-Christophe Lagier, Philippe Parola, Philippe Brouqui, Didier Raoult |
| 206 |
[GO] |
2020―Mai―20 |
SARS-CoV-2: virus mutations in specific European populations |
Frédérique Coppée, Jérôme Lechien, Anne-Emilie Declèves, Lionel Tafforeau, Sven Saussez |
| 207 |
[GO] |
2020―Mai―19 |
The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19 |
Fawad A. Khan |
| 208 |
[GO] |
2020―Mai―13 |
Report of 5 nurses infecting COVID-19 during patient care: case Series |
Ali Gheysarzadeh, Nourkhoda Sadeghifard, Maryam Safari, Firooz Balavandi, Shahab Falahi, Azra Kenarkoohi, Hamed Tavan |
| 209 |
[GO] |
2020―Apr―30 |
Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome |
A.P. Earhart, Z.M. Holliday, H.V. Hofmann, A.G. Schrum |
| 210 |
[GO] |
2020―Apr―22 |
Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance |
Renuka Choudhary, Anil K. Sharma, Renuka Choudhary |
| 211 |
[GO] |
2020―Apr―20 |
A short review on antibody therapy for COVID-19 |
G. Venkat Kumar, V. Jeyanthi, S. Ramakrishnan |
| 212 |
[GO] |
2020―Apr―14 |
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19 |
S. Saqrane, M.A. El Mhammedi |
| 213 |
[GO] |
2020―Apr―14 |
Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics) |
Saima Hamid, Mohammad Yaseen Mir, Gulab Khan Rohela |
| 214 |
[GO] |
2020―Apr―14 |
COVID-19 outbreak: current scenario of Pakistan |
A. Waris, U.K. Atta, M. Ali, A. Asmat, A. Baset |
| 215 |
[GO] |
2020―Apr―13 |
All about COVID-19 in brief |
A. Naserghandi, S.F. Allameh, R. Saffarpour |
| 216 |
[GO] |
2020―Apr―08 |
The preventive strategies of GI physicians during the COVID-19 pandemic |
Ahmad Hormati, Mohammad Reza Ghadir, Farhad Zamani, Javad Khodadadi, Mahboubeh Afifian, Sajjad Ahmadpour |
| 217 |
[GO] |
2020―Apr―04 |
Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future |
Ali A. Dawood |
| 218 |
[GO] |
2020―Apr―04 |
A Sever case of of SARS-CoV-2 infection in Gansu |
Yingjie Zhang, Liping Zhang |
| 219 |
[GO] |
2020―Mrz―31 |
Epidemiology, genome, and clinical features of the pandemic SARSCoV-2: a recent view |
Jameel M. Abduljalil, Bothainah M. Abduljalil |